Physician Payment Sunshine: PriMed Survey Showed Proposed Rules Could Lead…
PriMed recently submitted comments regarding Section 6002 of the Patient Protection Affordable Care Act (PPACA)—also known as the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
UCSF Editorial: Industry Support of CME are We on the Tipping Point –…
Accredited continuing medical education (CME) refers to those educational activities that have been deemed to meet the…
Doc Fix Money from Prevention to Pay Physicians
Earlier this month, President Obama signed legislation (H.R. 3630) that includes a 10-month doc fix. The $143 billion package…
Increasing Generic Drug Shortages Linked to Government Price Controls
As we previously noted, the Food and Drug Administration (FDA) recently released guidance to industry regarding the reporting of…
FDA: FDAA DTC Television Ad Pre-Dissemination Review Program
Over the past few years, Congress and media have paid increased attention to direct-to-consumer (DTC) television advertisements…
Continuing Medical Education and Conflict of Interest: The Bottom Line
Providers and supporters of continuing medical education (CME) "have gotten the message" and are delivering content without…
Merck Collaboration California Institute for Biomedical Research
In order to accelerate the translation of basic biomedical research into innovative, new medicines to treat disease, Merck…
Continuing Medical Education Advances Confidence of Clinicians Treating…
A recent study published in Critical Pathways in Cardiology analyzed the results of a continuing medical education (CME) program…
Stryker Biotech: Case Dismissed Charges Dropped
Over the past few years, there has been no shortage of legal cases brought by federal and state prosecutors against drug and…
GAO Report Drug Pricing: Research on Savings from Generic Drug Use
Since the Drug Price Competition and Patent Term Restoration Act of 1984—commonly known as the Hatch-Waxman Act—generic drugs have…